Sanara MedTech Inc. (SMTI)

23.01 +0.86 (+3.88%) At close: 04:00PM EDT

Sanara MedTech Inc.

1200 Summit Avenue
Suite 414
Fort Worth, TX 76102
United States
817 529 2300
https://sanaramedtech.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 63

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Ronald T. Nixon	Exec. Chairman	N/A	N/A	1956
Mr. Zachary B. Fleming	Chief Exec. Officer	365.8k	N/A	1975
Mr. Michael D. McNeil	CFO & Corp. Sec.	286.76k	N/A	1965
Mr. Shawn M. Bowman	Pres of Strategic Partnerships	286.52k	N/A	1976
Mr. Callon Nichols	Director of Investor Relations	N/A	N/A	N/A
Mr. Bill Fitzgerald	Compliance Officer	N/A	N/A	N/A
Dr. Jane A. Fore	Chief Medical Officer	N/A	N/A	N/A
Ms. Tricia Matteson	Sr. Director of Marketing	N/A	N/A	N/A
Ms. Carla Day	Director of Customer & Sales Services	N/A	N/A	N/A
Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D.	Pres of Telehealth Services	N/A	N/A	1970

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Corporate Governance

Sanara MedTech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.